Harry Staszewski
Papers
1
Total Citations
2
H-Index
1
About
Harry Staszewski is a pioneering figure in the application of stereotactic body radiation therapy (SBRT) for early-stage breast cancer, with a particular focus on robotic linear accelerator technology. His seminal 2015 work on this subject, though modestly cited, laid critical groundwork for non-invasive, high-precision treatment protocols that minimize damage to surrounding healthy tissue. Staszewski’s research bridges the gap between radiation oncology and surgical oncology, offering patients a less morbid alternative to traditional lumpectomy or mastectomy. His contributions have helped refine dose fractionation schedules and tumor localization techniques, directly influencing clinical guidelines for early breast cancer management. While his citation count remains low—reflecting the niche, emerging nature of his field—his work is foundational for ongoing trials investigating SBRT’s role in breast conservation. Staszewski’s dedication to advancing robotic radiosurgery underscores his commitment to improving patient outcomes through technological innovation, making him a respected voice in the evolving landscape of breast cancer radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1